What is the projected market valuation for the Magnetic Resonance Imaging MRI Equipment Market in 2035?

The projected market valuation for the Magnetic Resonance Imaging MRI Equipment Market in 2035 is 17.34 USD Billion. Read More

What is the expected CAGR for the Magnetic Resonance Imaging MRI Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the Magnetic Resonance Imaging MRI Equipment Market during the forecast period 2025 - 2035 is 4.58%. Read More

Which companies are considered key players in the Magnetic Resonance Imaging MRI Equipment Market?

Key players in the Magnetic Resonance Imaging MRI Equipment Market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems. Read More

What are the market segments based on field strength in the Magnetic Resonance Imaging MRI Equipment Market?

The market segments based on field strength include 1.5 Tesla, 3 Tesla, and Ultra-high Field, with valuations ranging from 4.5 to 3.64 USD Billion. Read More

How does the configuration of MRI systems impact market valuation?

The configuration of MRI systems, including Open MRI, Closed MRI, and Upright MRI, shows valuations from 2.12 to 10.12 USD Billion. Read More

What is the weight capacity segmentation in the Magnetic Resonance Imaging MRI Equipment Market?

The weight capacity segmentation includes categories such as Less than 200 lbs, 200-300 lbs, and Over 400 lbs, with valuations from 2.12 to 5.09 USD Billion. Read More

Which clinical applications are driving growth in the Magnetic Resonance Imaging MRI Equipment Market?

Clinical applications driving growth include Neuroimaging, Musculoskeletal Imaging, and Oncology Imaging, with valuations from 1.5 to 4.8 USD Billion. Read More

What is the valuation range for the 1.5 Tesla MRI segment?

The valuation range for the 1.5 Tesla MRI segment is from 4.5 to 7.2 USD Billion. Read More

How does the market for Closed MRI systems compare to other configurations?

The market for Closed MRI systems is notably larger, with a valuation range of 6.34 to 10.12 USD Billion, compared to other configurations. Read More

Magnetic Resonance Imaging Equipment Market

Q: What was the overall market valuation for the Magnetic Resonance Imaging MRI Equipment Market in 2024?

The overall market valuation for the Magnetic Resonance Imaging MRI Equipment Market in 2024 was 10.59 USD Billion. Read More

ID: MRFR/PCM/26018-HCR

100 Pages

Snehal Singh

Last Updated: April 06, 2026

Magnetic Resonance Imaging MRI Equipment Market Research Report: By Field Strength (0.5 Tesla, 1.5 Tesla, 3 Tesla, 7 Tesla, Ultra-high Field (Above 7 Tesla)), By Configuration (Open MRI, Closed MRI, Upright MRI), By Weight Capacity (Less than 200 lbs, 200-300 lbs, 300-400 lbs, Over 400 lbs), By Clinical Application (Neuroimaging, Musculoskeletal Imaging, Cardiovascular Imaging, Oncology Imaging, Gastrointestinal Imaging) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Magnetic Resonance Imaging Equipment Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Packaging & Transport, BY Field Strength (USD Billion)
4.1.1 1.5 Tesla
4.1.2 3 Tesla
4.1.3 Ultra-high Field
4.2 Packaging & Transport, BY Configuration (USD Billion)
4.2.1 Open MRI
4.2.2 Closed MRI
4.2.3 Upright MRI
4.3 Packaging & Transport, BY Weight Capacity (USD Billion)
4.3.1 Less than 200 lbs
4.3.2 200-300 lbs
4.3.3 300-400 lbs
4.3.4 Over 400 lbs
4.4 Packaging & Transport, BY Clinical Application (USD Billion)
4.4.1 Neuroimaging
4.4.2 Musculoskeletal Imaging
4.4.3 Cardiovascular Imaging
4.4.4 Oncology Imaging
4.4.5 Gastrointestinal Imaging
4.5 Packaging & Transport, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Packaging & Transport
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Siemens Healthineers (DE)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 GE Healthcare (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Philips Healthcare (NL)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Canon Medical Systems (JP)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Hitachi Medical Systems (JP)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Fujifilm Holdings Corporation (JP)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Bruker Corporation (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Esaote S.p.A. (IT)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Neusoft Medical Systems (CN)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY FIELD STRENGTH
6.4 US MARKET ANALYSIS BY CONFIGURATION
6.5 US MARKET ANALYSIS BY WEIGHT CAPACITY
6.6 US MARKET ANALYSIS BY CLINICAL APPLICATION
6.7 CANADA MARKET ANALYSIS BY FIELD STRENGTH
6.8 CANADA MARKET ANALYSIS BY CONFIGURATION
6.9 CANADA MARKET ANALYSIS BY WEIGHT CAPACITY
6.10 CANADA MARKET ANALYSIS BY CLINICAL APPLICATION
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY FIELD STRENGTH
6.13 GERMANY MARKET ANALYSIS BY CONFIGURATION
6.14 GERMANY MARKET ANALYSIS BY WEIGHT CAPACITY
6.15 GERMANY MARKET ANALYSIS BY CLINICAL APPLICATION
6.16 UK MARKET ANALYSIS BY FIELD STRENGTH
6.17 UK MARKET ANALYSIS BY CONFIGURATION
6.18 UK MARKET ANALYSIS BY WEIGHT CAPACITY
6.19 UK MARKET ANALYSIS BY CLINICAL APPLICATION
6.20 FRANCE MARKET ANALYSIS BY FIELD STRENGTH
6.21 FRANCE MARKET ANALYSIS BY CONFIGURATION
6.22 FRANCE MARKET ANALYSIS BY WEIGHT CAPACITY
6.23 FRANCE MARKET ANALYSIS BY CLINICAL APPLICATION
6.24 RUSSIA MARKET ANALYSIS BY FIELD STRENGTH
6.25 RUSSIA MARKET ANALYSIS BY CONFIGURATION
6.26 RUSSIA MARKET ANALYSIS BY WEIGHT CAPACITY
6.27 RUSSIA MARKET ANALYSIS BY CLINICAL APPLICATION
6.28 ITALY MARKET ANALYSIS BY FIELD STRENGTH
6.29 ITALY MARKET ANALYSIS BY CONFIGURATION
6.30 ITALY MARKET ANALYSIS BY WEIGHT CAPACITY
6.31 ITALY MARKET ANALYSIS BY CLINICAL APPLICATION
6.32 SPAIN MARKET ANALYSIS BY FIELD STRENGTH
6.33 SPAIN MARKET ANALYSIS BY CONFIGURATION
6.34 SPAIN MARKET ANALYSIS BY WEIGHT CAPACITY
6.35 SPAIN MARKET ANALYSIS BY CLINICAL APPLICATION
6.36 REST OF EUROPE MARKET ANALYSIS BY FIELD STRENGTH
6.37 REST OF EUROPE MARKET ANALYSIS BY CONFIGURATION
6.38 REST OF EUROPE MARKET ANALYSIS BY WEIGHT CAPACITY
6.39 REST OF EUROPE MARKET ANALYSIS BY CLINICAL APPLICATION
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY FIELD STRENGTH
6.42 CHINA MARKET ANALYSIS BY CONFIGURATION
6.43 CHINA MARKET ANALYSIS BY WEIGHT CAPACITY
6.44 CHINA MARKET ANALYSIS BY CLINICAL APPLICATION
6.45 INDIA MARKET ANALYSIS BY FIELD STRENGTH
6.46 INDIA MARKET ANALYSIS BY CONFIGURATION
6.47 INDIA MARKET ANALYSIS BY WEIGHT CAPACITY
6.48 INDIA MARKET ANALYSIS BY CLINICAL APPLICATION
6.49 JAPAN MARKET ANALYSIS BY FIELD STRENGTH
6.50 JAPAN MARKET ANALYSIS BY CONFIGURATION
6.51 JAPAN MARKET ANALYSIS BY WEIGHT CAPACITY
6.52 JAPAN MARKET ANALYSIS BY CLINICAL APPLICATION
6.53 SOUTH KOREA MARKET ANALYSIS BY FIELD STRENGTH
6.54 SOUTH KOREA MARKET ANALYSIS BY CONFIGURATION
6.55 SOUTH KOREA MARKET ANALYSIS BY WEIGHT CAPACITY
6.56 SOUTH KOREA MARKET ANALYSIS BY CLINICAL APPLICATION
6.57 MALAYSIA MARKET ANALYSIS BY FIELD STRENGTH
6.58 MALAYSIA MARKET ANALYSIS BY CONFIGURATION
6.59 MALAYSIA MARKET ANALYSIS BY WEIGHT CAPACITY
6.60 MALAYSIA MARKET ANALYSIS BY CLINICAL APPLICATION
6.61 THAILAND MARKET ANALYSIS BY FIELD STRENGTH
6.62 THAILAND MARKET ANALYSIS BY CONFIGURATION
6.63 THAILAND MARKET ANALYSIS BY WEIGHT CAPACITY
6.64 THAILAND MARKET ANALYSIS BY CLINICAL APPLICATION
6.65 INDONESIA MARKET ANALYSIS BY FIELD STRENGTH
6.66 INDONESIA MARKET ANALYSIS BY CONFIGURATION
6.67 INDONESIA MARKET ANALYSIS BY WEIGHT CAPACITY
6.68 INDONESIA MARKET ANALYSIS BY CLINICAL APPLICATION
6.69 REST OF APAC MARKET ANALYSIS BY FIELD STRENGTH
6.70 REST OF APAC MARKET ANALYSIS BY CONFIGURATION
6.71 REST OF APAC MARKET ANALYSIS BY WEIGHT CAPACITY
6.72 REST OF APAC MARKET ANALYSIS BY CLINICAL APPLICATION
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY FIELD STRENGTH
6.75 BRAZIL MARKET ANALYSIS BY CONFIGURATION
6.76 BRAZIL MARKET ANALYSIS BY WEIGHT CAPACITY
6.77 BRAZIL MARKET ANALYSIS BY CLINICAL APPLICATION
6.78 MEXICO MARKET ANALYSIS BY FIELD STRENGTH
6.79 MEXICO MARKET ANALYSIS BY CONFIGURATION
6.80 MEXICO MARKET ANALYSIS BY WEIGHT CAPACITY
6.81 MEXICO MARKET ANALYSIS BY CLINICAL APPLICATION
6.82 ARGENTINA MARKET ANALYSIS BY FIELD STRENGTH
6.83 ARGENTINA MARKET ANALYSIS BY CONFIGURATION
6.84 ARGENTINA MARKET ANALYSIS BY WEIGHT CAPACITY
6.85 ARGENTINA MARKET ANALYSIS BY CLINICAL APPLICATION
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY FIELD STRENGTH
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY CONFIGURATION
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY WEIGHT CAPACITY
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY CLINICAL APPLICATION
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY FIELD STRENGTH
6.92 GCC COUNTRIES MARKET ANALYSIS BY CONFIGURATION
6.93 GCC COUNTRIES MARKET ANALYSIS BY WEIGHT CAPACITY
6.94 GCC COUNTRIES MARKET ANALYSIS BY CLINICAL APPLICATION
6.95 SOUTH AFRICA MARKET ANALYSIS BY FIELD STRENGTH
6.96 SOUTH AFRICA MARKET ANALYSIS BY CONFIGURATION
6.97 SOUTH AFRICA MARKET ANALYSIS BY WEIGHT CAPACITY
6.98 SOUTH AFRICA MARKET ANALYSIS BY CLINICAL APPLICATION
6.99 REST OF MEA MARKET ANALYSIS BY FIELD STRENGTH
6.100 REST OF MEA MARKET ANALYSIS BY CONFIGURATION
6.101 REST OF MEA MARKET ANALYSIS BY WEIGHT CAPACITY
6.102 REST OF MEA MARKET ANALYSIS BY CLINICAL APPLICATION
6.103 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF PACKAGING & TRANSPORT
6.106 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
6.107 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
6.108 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
6.109 PACKAGING & TRANSPORT, BY FIELD STRENGTH, 2024 (% SHARE)
6.110 PACKAGING & TRANSPORT, BY FIELD STRENGTH, 2024 TO 2035 (USD Billion)
6.111 PACKAGING & TRANSPORT, BY CONFIGURATION, 2024 (% SHARE)
6.112 PACKAGING & TRANSPORT, BY CONFIGURATION, 2024 TO 2035 (USD Billion)
6.113 PACKAGING & TRANSPORT, BY WEIGHT CAPACITY, 2024 (% SHARE)
6.114 PACKAGING & TRANSPORT, BY WEIGHT CAPACITY, 2024 TO 2035 (USD Billion)
6.115 PACKAGING & TRANSPORT, BY CLINICAL APPLICATION, 2024 (% SHARE)
6.116 PACKAGING & TRANSPORT, BY CLINICAL APPLICATION, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.2.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.2.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.2.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.3.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.3.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.3.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.4.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.4.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.4.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.5.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.5.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.5.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.6.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.6.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.6.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.7.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.7.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.7.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.8.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.8.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.8.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.9.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.9.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.9.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.10.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.10.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.10.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.11.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.11.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.11.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.12.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.12.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.12.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.13.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.13.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.13.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.14.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.14.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.14.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.15.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.15.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.15.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.16.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.16.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.16.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.17.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.17.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.17.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.18.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.18.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.18.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.19.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.19.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.19.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.20.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.20.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.20.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.21.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.21.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.21.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.22.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.22.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.22.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.23.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.23.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.23.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.24.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.24.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.24.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.25.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.25.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.25.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.26.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.26.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.26.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.27.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.27.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.27.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.28.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.28.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.28.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.29.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.29.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.29.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
7.30.2 BY CONFIGURATION, 2025-2035 (USD Billion)
7.30.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
7.30.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Packaging & Transport Market Segmentation

Packaging & Transport By Field Strength (USD Billion, 2025-2035)

1.5 Tesla
3 Tesla
Ultra-high Field

Packaging & Transport By Configuration (USD Billion, 2025-2035)

Open MRI
Closed MRI
Upright MRI

Packaging & Transport By Weight Capacity (USD Billion, 2025-2035)

Less than 200 lbs
200-300 lbs
300-400 lbs
Over 400 lbs

Packaging & Transport By Clinical Application (USD Billion, 2025-2035)

Neuroimaging
Musculoskeletal Imaging
Cardiovascular Imaging
Oncology Imaging
Gastrointestinal Imaging

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓